Deferasorox
- Product NDC
- 69539-200
- 11-digit product format
- 695390200
- Labeler code
- 69539
- Product ID
- 69539-200_40154b92-b71c-4ccc-b959-99b5c1528d25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- GRANULE
- Route
- ORAL
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Application
- ANDA214650
- Marketing category
- ANDA
- Marketing start
- 2021-03-18
- Marketing end
- 0000-00-00
- Substance
- DEFERASIROX
- Active strength
- 360 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69539-200 | DEFERASOROX (DEFERASIROX) GRANULE [MSN LABORATORIES PRIVATE LIMITED] | 2 | Legacy NDC | 20220503_97a62d3d-b910-4d2d-abf6-19ffa33e7005.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69539-200-30 | 69539020030 | 30 PACKET in 1 CARTON (69539-200-30) > 1 GRANULE in 1 PACKET (69539-200-62) | 30 packet | 2021-03-18 | 0000-00-00 | No | No | Current |